Introduction
Most career discussions about restructuring focus on the typical pathway: enter Rx as a summer analyst, complete a 2-3 year analyst program, then exit to a distressed credit hedge fund or special situations PE firm. A smaller but meaningful subset of Rx analysts choose a different path: lateral into M&A coverage at a peer firm, either to gain sector specialization, target traditional buyout PE exits, or simply to find a better cultural fit.
This article walks through:
- when Rx-to-M&A laterals make sense
- the timing considerations
- how to position the transition successfully
When the Lateral Makes Sense
Several specific situations make a Rx-to-M&A lateral a reasonable career move:
- Sector specialization interest. Some Rx analysts develop interest in specific industries (technology, healthcare, energy) that they encountered through Rx mandates and want to pursue more deeply. M&A coverage groups offer sustained sector exposure that Rx generalist work does not provide.
- Traditional buyout PE targeting. Candidates who want to recruit for traditional buyout PE (KKR, Blackstone, Carlyle, Apollo's flagship fund, TPG) sometimes find that M&A coverage backgrounds open more doors than Rx backgrounds. While distressed PE values Rx work directly, traditional buyout PE recruiters sometimes favor M&A-trained associates.
- Cultural fit issues. A candidate who joins a Rx firm and finds the culture, deal flow, or work content not aligned with their interests may lateral to a peer M&A group as a course correction.
- Brand upgrade. A candidate at a Tier 2 Rx firm may lateral to a Tier 1 M&A coverage group to upgrade brand prestige for long-term career flexibility.
Timing the Lateral Move
Investment banking lateral hiring follows predictable seasonal patterns driven by bonus cycles and hiring budgets.
| Window | Activity Level | Best For |
|---|---|---|
| August-September | Highest | Post-bonus moves, planned career changes |
| October-November | Moderate | Year-end hiring before bonus cycles |
| December-January | Lower | Limited hiring during bonus determination |
| February-April | Moderate | Post-bonus second wave |
| May-July | Lower | Year-end summer slowdown |
August-September is the optimal window because most analyst bonuses are paid in July, making this the period when departing analysts are most likely to leave their current firm and when receiving firms can budget for new hires before year-end.
The seniority sweet spot for lateral moves is typically the associate level (post-promotion from analyst). At associate level, candidates have enough deal experience to demonstrate value, sufficient seniority to negotiate effectively, and the runway to develop sector relationships at the new firm. Lateral analyst-level moves happen but are less common.
Which Firms Accept Rx-to-M&A Laterals
Most major M&A coverage groups will consider Rx-to-M&A laterals if the candidate's profile fits, though the receptivity varies by firm:
- Bulge brackets (JPM, Goldman, Morgan Stanley, BofA, Citi). Generally receptive to lateral hires from Rx backgrounds, particularly at associate level. Bulge bracket M&A groups value the technical depth that Rx-trained candidates bring.
- Elite boutiques with M&A and Rx (Evercore, Lazard, Moelis). Internal lateral moves between Rx and M&A within the same firm are sometimes possible. External laterals between firms in this tier are less common but happen.
- Pure M&A elite boutiques (Centerview, Greenhill, PWP). Selective on Rx laterals, with a preference for candidates who have worked on both Rx and M&A mandates rather than pure-Rx specialists.
- M&A-focused groups within Rx-heavy firms (PJT Strategic Advisory). Internal moves from RSSG to PJT's Strategic Advisory practice happen but are not common.
Positioning the Transition
A successful Rx-to-M&A lateral requires a clear narrative about why the move makes sense. Common framings include:
- Sector commitment narrative. "I worked on three healthcare-related Rx mandates and developed deep interest in healthcare M&A, particularly in PE-backed physician practice management. I want to pursue healthcare M&A specifically and PJT/HL doesn't have a dedicated healthcare M&A bench."
- Skill-broadening narrative. "I've built strong distressed analytical skills at HL FR over 18 months. I want to develop traditional M&A capabilities (LBO modeling, M&A precedent analysis, sector-specific work) before moving to buy-side. M&A coverage at a strong firm is the right next step."
- Career flexibility narrative. "I'm not sure whether I want to focus on distressed strategies long-term or pursue traditional buyout PE. M&A coverage gives me optionality on both paths."
Trade-offs to Consider
The Rx-to-M&A lateral involves several specific trade-offs candidates should weigh:
- Technical specialization loss. Rx-specific skills (recovery waterfalls, claims trading, post-Purdue plan structures) become less relevant in M&A work. Candidates who have invested in deep Rx expertise may feel they are leaving valuable specialization behind.
- Compensation impact. Lateral moves typically maintain compensation level or modestly improve it, but the boutique premium gap can shift based on which firms are involved. Moving from a Tier 1 Rx boutique to a bulge bracket M&A group may modestly reduce compensation.
- Exit pathway shift. Distressed credit hedge fund and special situations PE recruiting becomes less natural after an M&A lateral. Candidates planning to recruit for these exits should think carefully before lateraling away from Rx.
- Network considerations. A lateral move means rebuilding relationships at the new firm. Senior banker references and informal mentorship developed at the prior firm partially carry over but are less effective than continued tenure.
When Not to Lateral
Several scenarios suggest staying at the current Rx firm rather than lateraling:
- The candidate plans to recruit for distressed credit hedge funds or special situations PE in the next 12-18 months
- The current firm has the dominant Rx franchise (PJT RSSG, HL FR) and the candidate's career goals align with Rx
- The candidate has strong relationships with senior bankers at the current firm that would not transfer
- The lateral move would represent a brand downgrade
- The candidate is in early Year 1 and has not yet developed enough deal experience to lateral effectively
The Internal Lateral Option
Several Rx firms support internal lateral moves between Rx and M&A practices, sometimes as a less disruptive alternative to external lateral moves:
- PJT Partners. Internal moves between Restructuring & Special Situations Group (RSSG) and Strategic Advisory practice happen occasionally, typically at associate or senior associate level. The internal move preserves firm tenure, senior banker relationships, and brand continuity while allowing the candidate to develop different skills.
- Lazard. Lazard's combined platform makes internal moves between Rx and M&A coverage relatively straightforward. The firm has facilitated Rx-to-M&A internal moves at multiple levels.
- Evercore. Evercore's M&A and Rx practices are partially separate but share enough culture and senior banker overlap to support internal moves.
- Moelis. Moelis's smaller scale and integrated culture make internal moves practical, though the dedicated Rx team is small enough that internal moves are less frequent.
The internal lateral option, where available, is often the better choice than external lateral moves because it preserves accumulated tenure value while allowing skill development.
What This Means for Career Planning
For most Rx analysts, the lateral move is not the right path. The Rx specialization, the buy-side exit pathway, and the senior partner relationships at top Rx firms are too valuable to abandon mid-program. The lateral makes sense for the specific subset of candidates whose long-term goals genuinely require M&A coverage exposure or whose current situation has structural issues that an internal solution cannot address.
The next six articles in this section drill into the interview process for Rx roles specifically, the technical question bank that candidates need to master, and the specific framing that differentiates strong Rx interview answers.
Free Interview PDF Guide